<DOC>
	<DOCNO>NCT01906593</DOCNO>
	<brief_summary>To monitor safety Beijing Tiantan Biological 's influenza vaccine elderly Adverse Events Following Immunization Surveillance System China . The hypothesis significant difference occurrence adverse event among influenza vaccine manufacture independent company .</brief_summary>
	<brief_title>A Post-marketing Safety Study Beijing Tiantan Biological 's Influenza Virus Vaccine Elderly</brief_title>
	<detailed_description>In 2011 2012 , Beijing Municipal Health Bureau launch free influenza vaccination campaign among child age 6-18 year old elderly age 60 year old . Inactivated split-virion vaccine Beijing Tiantan Biological Products Company use elderly campaign . All vaccine recipient provide write informed consent , contain information vaccine , possible adverse effect , medical care . Adverse event collect National Immunization Information System 's National Adverse Events Following Immunization ( AEFI ) Surveillance System , establish 2005 basis World Health Organization ( WHO ) guideline . According Guideline Identification Adverse Reaction Immunization issue Chinese Ministry Health 2008 , Beijing CDC local prefectural CDC must organize expert panel investigate adverse event assess causality , use criterion base Chinese Standard Procedures Vaccination . The panel consist physician , epidemiologist , pharmacist , relevant expert . In general , expert panel investigate death , life-threatening illness , permanent disability , immunization-program manager vaccination provider investigate common , minor adverse event . Adverse event classify one five category : vaccine reaction ( common minor rare serious ) , program error , coincidental illness , psychogenic reaction , unclassifiable event . At time vaccination , vaccinee instruct report adverse event physician vaccination provider . Adverse event fatal result disability cluster event ( i.e. , notably high number similar adverse event related certain vaccine ) require report within 2 hour occurrence . The following adverse event require report within 2 day occurrence : anaphylaxis allergic reaction occur within 24 hour vaccination ; fever ( axillary temperature , &gt; 37.5°C ) , angioedema , local injection-site reaction ( diameter , &gt; 2.5 cm ) occur within 5 day vaccination ; purpura , Arthus reaction , febrile convulsion , seizure , polyneuritis occur within 15 day vaccination ; Guillain-Barré syndrome occur within 3 month vaccination . Other reaction common minor ( e.g. , mild pain fatigue ) require report .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>1 . Males female age 60 year day immunization , eligible seasonal influenza vaccination . 2 . In judgement study doctor determine reasonable health consider age able comply study procedure . 1 . History serious reaction flu vaccine , material vaccine , egg ( include ovalbumin ) chicken protein . 2 . Receipt live vaccine within 4 week prior Study Day 1 . 3 . Any condition , opinion study doctor , might interfere evaluation study objective .</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>safety</keyword>
	<keyword>influenza vaccine</keyword>
	<keyword>post-marketing</keyword>
</DOC>